COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran.

Autor: Esmaeeli H; Cardiology Department, School of Medicine, Gorgan University of Medical Sciences, Gorgan, Iran., Ghaderian M; Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran., Zanjani KS; Cardiology Division, Pediatric Department, Children's Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, Iran., Ghalibafan SF; Mashhad University of Medical Sciences, Mashhad, Iran., Mahdizadeh M; Radiology Division, Children's Medical Center (Pediatric Center of Excellence), Tehran University of Medical Sciences, Tehran, Iran., Aelami MH; Department of Pediatrics and Hand Hygiene and Infection Control Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Jazyk: angličtina
Zdroj: Case reports in pediatrics [Case Rep Pediatr] 2021 Apr 17; Vol. 2021, pp. 6690695. Date of Electronic Publication: 2021 Apr 17 (Print Publication: 2021).
DOI: 10.1155/2021/6690695
Abstrakt: Background: Promptly discovering and counteracting COVID-19 is critical as it could have catastrophic effects. As an asymptomatic group, children are highly susceptible to be misdiagnosed, especially those suffering from underlying diseases. Furthermore, discriminating the direct effects of the virus from those of the underlying diseases can pose a dilemma to physicians. This case series aims to determine the relationship between COVID-19 and various types of congenial heart disease among children. Patients and Methods . Seven patients from three different medical centers were enrolled. Their detailed demographic information, past medical history, symptoms, type of congenital heart diseases, imaging tests, laboratory tests, medications, and outcomes were analyzed.
Results: The patients included 4 infants, 1 child, and 2 adolescents, with a median age of 9 months and a majority of boys. All of them had either obstructive lesions (right or left ventricular outflow tracts) or significant pulmonary hypertension. The more common clinical symptoms were cough, dyspnea, and fever. Two patients did not survive the illness.
Conclusion: Prompt treatment of patients with a combination of COVID-19 and severe obstructive cardiac pathology or pulmonary hypertension is essential due to a risk for serious and/or fatal consequences.
Competing Interests: The authors declare that they have no conflicts of interest.
(Copyright © 2021 Hassan Esmaeeli et al.)
Databáze: MEDLINE
Externí odkaz: